1. Home
  2. IPSC vs SIDU Comparison

IPSC vs SIDU Comparison

Compare IPSC & SIDU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPSC
  • SIDU
  • Stock Information
  • Founded
  • IPSC 2019
  • SIDU 2012
  • Country
  • IPSC United States
  • SIDU United States
  • Employees
  • IPSC N/A
  • SIDU N/A
  • Industry
  • IPSC Medicinal Chemicals and Botanical Products
  • SIDU Telecommunications Equipment
  • Sector
  • IPSC Health Care
  • SIDU Telecommunications
  • Exchange
  • IPSC Nasdaq
  • SIDU Nasdaq
  • Market Cap
  • IPSC 45.4M
  • SIDU 37.7M
  • IPO Year
  • IPSC 2021
  • SIDU 2021
  • Fundamental
  • Price
  • IPSC $0.55
  • SIDU $0.70
  • Analyst Decision
  • IPSC Strong Buy
  • SIDU
  • Analyst Count
  • IPSC 6
  • SIDU 0
  • Target Price
  • IPSC $3.00
  • SIDU N/A
  • AVG Volume (30 Days)
  • IPSC 1.5M
  • SIDU 1.3M
  • Earning Date
  • IPSC 11-13-2025
  • SIDU 11-14-2025
  • Dividend Yield
  • IPSC N/A
  • SIDU N/A
  • EPS Growth
  • IPSC N/A
  • SIDU N/A
  • EPS
  • IPSC N/A
  • SIDU N/A
  • Revenue
  • IPSC $113,337,000.00
  • SIDU $3,623,538.00
  • Revenue This Year
  • IPSC $1,589.94
  • SIDU N/A
  • Revenue Next Year
  • IPSC N/A
  • SIDU $100.00
  • P/E Ratio
  • IPSC N/A
  • SIDU N/A
  • Revenue Growth
  • IPSC 4122.69
  • SIDU N/A
  • 52 Week Low
  • IPSC $0.34
  • SIDU $0.69
  • 52 Week High
  • IPSC $1.83
  • SIDU $7.65
  • Technical
  • Relative Strength Index (RSI)
  • IPSC 52.98
  • SIDU 32.15
  • Support Level
  • IPSC $0.46
  • SIDU $0.69
  • Resistance Level
  • IPSC $0.56
  • SIDU $0.76
  • Average True Range (ATR)
  • IPSC 0.04
  • SIDU 0.08
  • MACD
  • IPSC 0.00
  • SIDU -0.01
  • Stochastic Oscillator
  • IPSC 76.21
  • SIDU 3.04

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.

About SIDU Sidus Space Inc.

Sidus Space Inc is a Space and Defense as-a-Service company focused on providing complex space hardware, satellite/spacecraft design, manufacture, launch, and data solutions for both government and commercial in-space missions for all destinations through the solar system. This includes a Space-based infrastructure of multi-mission satellites with hyperspectral, multi-spectral, and other sensors to provide monitoring services and solutions to multiple sectors and industries. The company supports Commercial Space, Aerospace, Defense, Underwater Marine, and other commercial and government customers.

Share on Social Networks: